CYSVIEW
Drug
Photocure Inc
Total Payments
$1.1M
Transactions
2,035
Doctors
1,328
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $481,365 | 808 | 619 |
| 2023 | $453,635 | 676 | 519 |
| 2022 | $158,906 | 551 | 419 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $533,327 | 103 | 48.8% |
| Consulting Fee | $335,588 | 100 | 30.7% |
| Food and Beverage | $71,609 | 1,761 | 6.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $70,663 | 36 | 6.5% |
| Travel and Lodging | $59,471 | 26 | 5.4% |
| Honoraria | $23,250 | 9 | 2.1% |
Payments by Type
General
$560,579
1,932 transactions
Research
$533,327
103 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Blue Light Cystoscopy With Cysview Registry | Photocure Inc | $533,327 | 0 |
Ad
Manufacturing Companies
- Photocure Inc $1.1M
Product Information
- Type Drug
- Total Payments $1.1M
- Total Doctors 1,328
- Transactions 2,035
About CYSVIEW
CYSVIEW is a drug associated with $1.1M in payments to 1,328 healthcare providers, recorded across 2,035 transactions in the CMS Open Payments database. The primary manufacturer is Photocure Inc.
Payment data is available from 2022 to 2024. In 2024, $481,365 was paid across 808 transactions to 619 doctors.
The most common payment nature for CYSVIEW is "Unspecified" ($533,327, 48.8% of total).
CYSVIEW is associated with 1 research study, including "Blue Light Cystoscopy With Cysview Registry" ($533,327).